NOTICE: Many events listed here have been canceled or postponed due to the Covid-19 emergency. It is best to call ahead or check with organizer's websites to verify the status of any local event.

Change Location × San Francisco

    Recent Locations

      Biocompatibility Testing for Medical Devices in Daly City


      • Biocompatibility Testing for Medical Devices Photo #1
      1 of 1
      May 8, 2020

      Friday   8:30 AM - 12:30 PM (daily for 2 times)

      Daly City, California 94016

      Map
      Performers:
      • No Performers Listed
      EVENT DETAILS
      Biocompatibility Testing for Medical Devices

      Biocompatibility Testing for Medical Devices
      About this Event
      *** LIMITED TIME OFFER: FREE $100 AMAZON GIFT CARD! ***

      REGISTER TODAY!

      The medical device field is one of the most heavily regulated industries, for obvious reasons. Medical devices are an important tool in efforts to improve patient care and treatment outcomes. Learn how to achieve more successful biocompatibility testing outcomes by attending this seminar.

      Biocompatibility testing is in the spotlight with regulatory bodies – especially with the recent release of the updated European MDRs and the FDA’s Guidance document on ISO 10993-1. It is essential for medical device manufacturers to have an understanding of the current landscape for biocompatibility testing while keeping an eye on the future trends that will affect future requirements. This seminar will discuss the recent changes to regulatory documents and standards and how they will impact the overall biocompatibility assessment of medical devices.

      Attendees will understand and apply ISO 10993-1 and the FDA Guidance on its use. They will know how to use the ISO documents to locate information that you need. Understand what tests to select and how to choose among various options.

      By attending this seminar, attendees will get answers of these questions:

      When is testing not the only option?
      Understand how to apply Materials characterization, and more importantly learn how to use the information to understand biological safety?
      Understand ISO 14971 and how to use it?
      Learn how to use ISO 10993-1 as a tool for hazard identification?
      Learn how to develop a program that guides your device on the regulatory path and reduces your time to market?
      Practice how to execute your plan from development to completion and how to schedule and document the implementation of your biocompatibility plan.?
      Seminar Fee Includes:

      Lunch

      AM-PM Tea/Coffee

      Seminar Material

      USB with seminar presentation

      Hard copy of presentation

      Attendance Certificate

      $100 Gift Cert for next seminar

      Learning Objectives:

      After completing this seminar, participants should be familiar with the full scope of ISO 10993-1, including the current version. The topics covered will include:

      Gain a deeper understanding of global regulatory expectations for biological safety.
      Know how to review reports for accurate data and work with a laboratory when unexpected results are reported.
      Understand evaluating complexities for drug/device combination devices.
      Familiarization with calculating allowable limits for cancer, chemical mixtures, and assessment of unidentified chemicals.
      Experience working application with real life examples to calculate allowable limits, experience testing errors and how to mitigate them, and then manage a device from concept to market clearance.
      Gain knowledge on the principles of toxicology, FDA consensus standards, and Good Laboratory Practices.
      Learn the difference between evaluation and testing. Recognize when testing is absolutely necessary and how to avoid unnecessary test-ing.
      Areas Covered :

      The areas that will be discussed in the seminar will include the following topics throughout the agenda:

      History of ISO 19993-1
      Overview of collateral standards, i.e., 10993-X
      Risk based approach (for Biocompatibility)
      Review of ISO 14971 Risk management file
      Biocompatibility evaluation endpoints
      Endpoint assessment vs. testing
      Endpoint consideration: Test specific
      Chemical testing: Extractables and Leachables
      Toxicology assessment
      Who will Benefit:

      Consultants
      Technical advisors
      Product Managers
      Laboratory Managers
      Process Development and System Engineers
      Research, Design and Manufacturing Engineers
      Regulatory Affairs and Quality Assurance Professionals
      Microbiologists and Chemists involved in the evaluation of Medical Devices
      AGENDA

      DAY 01(8:30 AM - 4:30 PM)

      08.30 AM - 08.59 AM: Registration and Meet & Greet.

      09.00 AM - 10.00 AM:

      Seminar outline

      History of Biocompatibility testing

      10.00 AM - 11.00 AM: ISO 10993-1

      The general principles governing the biological evaluation of medical devices within a risk management process;

      The general categorization of devices based on the nature and duration of their contact with the body;

      The evaluation of existing relevant data from all sources;

      The identification of gaps in the available data set on the basis of a risk analysis;

      The identification of additional data sets necessary to analyse the biological safety of the medical device;

      The assessment of the biological safety of the medical device.

      11.00 AM - 12.00 PM: FDA & 10993-1

      ODE Final Biocompatibility Guidance Use of ISO 10993-1 “Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process” Published: June 16, 2016

      12.00 PM - 01.00 PM: Lunch

      01.00 PM - 02.00 PM: ISO 14971-Risk Assessment

      Have risks been designed out if possible?

      Have manufacturers shown that risks have been reduced as much as possible?

      Have manufacturers conducted a risk benefit analysis for all risks?

      Have residual risks been incorrectly reduced by warnings placed on IFUs or provided in training?

      02.00 PM - 03.00 PM: Developing a Biological Safety Plan

      Biological Safety: More than just Test Data

      Leverage information that is known about the constituents of the device

      Identify and characterize biological and toxicological hazards associated with the medical device product in an effort to characterize risk

      Define a plan for ensuring biological safety

      Explain how your company uses the requirements of ISO 109931:2003 to assure biological safety

      03.00 PM - 04.00 PM: Chemical Testing: Extractables & Leachables

      Regulators are concerned with substances migrating from different materials (polymers, metals, glass etc.) which patients may be exposed to through many different routes of administration.

      Extractables studies

      Leachables studies

      Analytical Techniques for Extractables and Leachables

      What do the results tell you?

      04.00 PM - 04.30 PM: Good laboratory practices

      What are they? How do they apply?

      DAY 02(8:30 AM - 12:30 PM)

      08.30 AM - 10.00 AM: ISO 10993-17 Allowable Limits

      Approach for setting tolerable intake (TI) values for chemical compounds released from medical device materials based on the method described in the standard

      Practical advice is provided on how to derive both non-cancer and cancer-based TI values

      10.00 PM - 12.00 PM: Biocompatibility Endpoints-Testing

      Use of ISO 10993-1 and the FDA-modified matrix (Attachment A) to determine the relevant biocompatibility endpoints for an evaluation

      General biocompatibility testing considerations, including test article preparation

      Specific considerations for the following testing: cytotoxicity, sensitization, hemocompatibility, pyrogenicity, implantation, genotoxicity, carcinogenicity, reproductive and developmental toxicity, and degradation assessments

      Chemical assessment recommendations

      Considerations for labeling devices as “-free”

      12.00 PM - 12.30 PM: Seminar wrap up

      SPEAKER

      Mike Colvin Ph.D

      Medical Device Technical Adviser/Consultant

      Mike has over 30 years’ experience developing medical devices and systems. Over his career he has been in charge of safety & efficacy testing and Regulatory & Clinical strategies. He has also served as a technical advisor/consultant in the medical device industry for over 25 years, giving him exposure to both large medical device companies and startups.

      Mike has taught college for over 25 years and has contributed/participated on many domestic and international technical committees. He holds a Ph.D. in Physical Chemistry from the University of Southern California/California Institute of Technology.

      Cost: $2,299

      Categories: Conferences & Tradeshows

      This event repeats daily for 2 times:

      Event details may change at any time, always check with the event organizer when planning to attend this event or purchase tickets.

      Hotels and Airbnbs near Biocompatibility Testing for Medical Devices. Book your stay now!